Stanford’s Department of Neurology is looking for people between the ages of 50 and 80 who have Parkinson’s disease to participate in a clinical trial investigating the tolerability, feasibility, and safety of young plasma infusions as a future potential treatment.
Parkinson’s Participants Needed for Stanford Study on Cognition and Movement
Stanford’s Department of Neurology is looking for people between the ages of 45 and 75 who have Parkinson’s disease to participate in an observational study to examine the effects of aging and disease progression on the brain.
Healthy Volunteers Needed for Stanford Parkinson’s Disease Study
Stanford’s Department of Neurology is seeking healthy volunteers between the ages of 35 and 85. This study will compare behavior and memory between people with Parkinson’s Disease and healthy people without Parkinson’s Disease. We hope to understand why some people with Parkinson’s disease develop memory problems.
FDA approves new formulation of amantadine for dyskinesia
The FDA has approved amantadine in a new formulation for the dyskinesia in Parkinson’s patients based on a Phase 3 randomized, double-blind, placebo-controlled study reported in JAMA Neurology.
ParkinsonsDisease.net – “Parkinson’s Disease—Going Beyond the Tremor”
The Parkinson’s Disease In America 2017 online survey gathered insights from 1,152 individuals currently suffering from Parkinson’s disease to better understand their symptoms and management of this condition, as well as the impact on their lives. Here are the survey findings…. Full Story>